Alpha 2.0
Login Register
» Authors » Ashley Stucky

Ashley Stucky

Explore the profile of Ashley Stucky including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 59
Followers 0
Related Specialties
Infectious Diseases
Allergy & Immunology
Microbiology
Top 10 Co-Authors
Koya Ariyoshi
Yuzo Arima
Chris Smith
Takeshi Arashiro
Motoi Suzuki
Martin Hibberd
Hideaki Oka
Kunihiro Oba
Hideaki Kato
Yusuke Nishida
Published In
Vaccine
Influenza Other Respir Viruses
Euro Surveill
Emerg Infect Dis
Open Forum Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study)
Arashiro T, Miwa M, Nakagawa H, Takamatsu J, Oba K, Fujimi S, et al.
Vaccine . 2023 Dec; 42(3):677-688. PMID: 38114409
Introduction: Since the SARS-CoV-2 Omicron variant became dominant, assessing COVID-19 vaccine effectiveness (VE) against severe disease using hospitalization as an outcome became more challenging due to incidental infections via admission...
2.
Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan
Arashiro T, Arima Y, Kuramochi J, Muraoka H, Sato A, Chubachi K, et al.
Vaccine . 2023 Oct; 41(47):6969-6979. PMID: 37839947
Background: Repeated emergence of variants with immune escape capacity and waning immunity from vaccination are major concerns for COVID-19. We examined whether the surge in Omicron subvariant BA.5 cases was...
3.
Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan
Arashiro T, Arima Y, Kuramochi J, Muraoka H, Sato A, Chubachi K, et al.
Open Forum Infect Dis . 2023 Jun; 10(6):ofad240. PMID: 37351451
In this multicenter, prospective, test-negative, case-control study in Japan, the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent coronavirus disease 2019 mRNA vaccines against symptomatic infection during the BA.5-dominant period was...
4.
Letter to the editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies
Arashiro T, Arima Y, Kuramochi J, Muraoka H, Sato A, Chubachi K, et al.
Euro Surveill . 2023 Jan; 28(4). PMID: 36700869
No abstract available.
5.
Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control...
Arashiro T, Arima Y, Muraoka H, Sato A, Oba K, Uehara Y, et al.
Clin Infect Dis . 2022 Aug; 76(3):e108-e115. PMID: 35918782
Background: Although several coronavirus disease 2019 (COVID-19) vaccines initially showed high efficacy, there have been concerns because of waning immunity and the emergence of variants with immune escape capacity. Methods:...
6.
Social and Behavioral Factors Associated with Lack of Intent to Receive COVID-19 Vaccine, Japan
Arashiro T, Arima Y, Stucky A, Smith C, Hibberd M, Ariyoshi K, et al.
Emerg Infect Dis . 2022 Jul; 28(9):1909-1910. PMID: 35793812
Persons in Japan who did not intend to receive COVID-19 vaccines after widespread rollout were less likely than others to engage in preventive measures or to be afraid of getting...
7.
Behavioral factors associated with SARS-CoV-2 infection in Japan
Arashiro T, Arima Y, Muraoka H, Sato A, Oba K, Uehara Y, et al.
Influenza Other Respir Viruses . 2022 Apr; 16(5):952-961. PMID: 35470969
Background: The relative burden of COVID-19 has been less severe in Japan. One reason for this may be the uniquely strict restrictions imposed upon bars/restaurants. To assess if this approach...